InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
3.120
-0.270 (-7.96%)
At close: Feb 21, 2025, 4:00 PM
3.190
+0.070 (2.24%)
After-hours: Feb 21, 2025, 7:31 PM EST
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $3.77 million as of February 21, 2025. Its market cap has increased by 121.55% in one year.
Market Cap
3.77M
Enterprise Value
1.26M
1-Year Change
121.55%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $3.77M, a decrease of -85.51%. That is a compound annual growth rate of -36.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.80M | 11.76% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |